SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹10 Cr | ₹9.63 Cr | ₹8.23 Cr | ₹18 Cr | ₹18 Cr |
What is the latest Short Term Loans and Advances ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Short Term Loans and Advances |
---|---|
Mar2024 | ₹10 Cr |
Mar2023 | ₹9.63 Cr |
Mar2022 | ₹8.23 Cr |
Mar2017 | ₹18 Cr |
Mar2016 | ₹18 Cr |
How is Short Term Loans and Advances of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2024 | ₹10 Cr | 8.94 | |
Mar2023 | ₹9.63 Cr | 16.97 | |
Mar2022 | ₹8.23 Cr | -53.05 | |
Mar2017 | ₹18 Cr | -4.81 | |
Mar2016 | ₹18 Cr | - |
Compare Short Term Loans and Advances of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,802.0 Cr | -10% | -2.7% | 48.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,249.0 Cr | -1.3% | -3.3% | 8.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,940.0 Cr | -1.5% | 0.8% | 42.3% | Stock Analytics | |
CIPLA | ₹121,197.0 Cr | -1.7% | 2.3% | -5.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,618.0 Cr | -1.6% | 8.4% | 10.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,250.0 Cr | -3.3% | -1.4% | 9.8% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -10% |
-2.7% |
48.3% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses